If you are unsure of your child’s risk and eligibility, contact his or her health care provider. All the children that Mayo Clinic Health System tests are screened to see if they are eligible for monoclonal antibody therapy. Monoclonal antibody therapy, which is designed to prevent COVID-19 from worsening, should be given as soon as possible after a COVID-19 diagnosis is made. Those at higher risk are children with severe asthma or other lung disease neuromuscular conditions, such as Down syndrome and cerebral palsy obesity and any condition that affects the immune system. Talk with your child’s health care provider if you have questions about managing symptoms.ĭespite mild initial symptoms, children 12 and older at higher risk of complications may be given monoclonal antibody therapy to help them fight the infection. Other symptoms, such as loss of taste and smell, cannot be treated specifically, but they generally resolve with time. Staying hydrated with adequate intake of fluids is encouraged, as with illnesses such as the flu.

Over-the counter pain and fever reducers, such as acetaminophen or ibuprofen, can be given as needed to relieve symptoms. Their symptoms often resemble a cold with congestion, cough, low-grade fever and fatigue. Many children with COVID-19 have minimal to no symptoms. Individual symptoms can vary, and these symptoms should be monitored carefully for short- and long-term complications. As another school year begins, the contagious delta variant of COVID-19 has infected more children and teens across the U.S.

Covid symptoms in kids temperature